# A Study in Japanese Healthy Men to Test How Well Different Doses of BI 3031185 Are Tolerated and a Study in Japanese Healthy Women to Test Whether BI 3031185 Influences the Amount of a Contraceptive in the Blood

> **NCT07656792** · PHASE1 · TERMINATED · sponsor: **Boehringer Ingelheim** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 3031185
- **DRUG:** Placebo matching BI 3031185
- **DRUG:** Midazolam
- **DRUG:** YAZ®

## Key facts

- **NCT ID:** NCT07656792
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2026-07-17
- **Primary completion:** 2026-09-23
- **Final completion:** 2026-09-23
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Sponsor decision - hold following the evaluation of a safety event. No current sites in the US.
- **Last updated:** 2026-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07656792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07656792, "A Study in Japanese Healthy Men to Test How Well Different Doses of BI 3031185 Are Tolerated and a Study in Japanese Healthy Women to Test Whether BI 3031185 Influences the Amount of a Contraceptive in the Blood". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07656792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*